GLP-1 and GIP receptor agonists have a low intrinsic risk of causing hypoglycaemia when used alone, because their insulin-stimulating effects are glucose-dependent
These analgesic properties position DSIP as valuable research compound for developing non-opioid pain management strategies, understanding the relationship between sleep and pain processing, and investigating peptide-based approaches to chronic pain treatment
For most healthy patients, yes
These injections offer fast, effective support for B12 deficiency, particularly when absorption issues make oral supplements less effective
Students seeking to boost memory and learning
Activity changes: Some experience fatigue or reduced energy on GLP-1s, leading to less physical activity and resistance training that would otherwise preserve muscle